Drugs / Compound lidocaine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| — | NCT05964985 Comparator | Aug 2023 → Jan 2024 | — | Tianjin Medical University General Hospital | Unknown | No outcome recorded |
| — | NCT05122338 Comparator | Dec 2021 → May 2022 | — | Tianjin Medical University General Hospital | Unknown | No outcome recorded |
| — | NCT04938882 Comparator | Aug 2021 → Feb 2022 | — | Tianjin Medical University General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound lidocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05964985 ↗ |
| Route | Other | “0.4% compound lidocaine is used for bilateral transversus abdominis plane block” NCT04938882 ↗ |